AMY1C, amylase alpha 1C, 278

N. diseases: 63; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0162429
Disease: Malnutrition
Malnutrition
0.020 AlteredExpression disease BEFREE Decreased sAA activity may reflect malnutrition state and be one potential marker of poor digestion, decreased salivary pH may contribute to bitter taste perception, and reduced TPD might be a cause of dry mouth in CNAG. 30597598 2019
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.020 Biomarker disease BEFREE Areas under the receiver operator characteristic analysis revealed that the cutoff values of salivary alpha-amylase for identifying moderate-severe OSA and OSA concomitant hypertension were 17.64 U/mL (sensitivity 85%, specificity 91%) and 25.35 U/mL (sensitivity 70%, specificity 94%), respectively. 31126512 2019
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.020 Biomarker disease BEFREE The present study was to investigate the effect of T&A on NE, the change of sAA value in ATH and OSAS children, with/without NE, and with/without the operation. 27876406 2017
CUI: C0700613
Disease: Anxiety state
Anxiety state
0.020 Biomarker disease BEFREE Immediately before and after a mindfulness session, participants completed questionnaires to assess the short-term effects on mood and state anxiety and provided saliva samples to assess salivary alpha amylase (sAA) concentrations. 30395806 2019
CUI: C0700613
Disease: Anxiety state
Anxiety state
0.020 Biomarker disease BEFREE No mediating roles of salivary alpha-amylase and anxiety state in the cGxE effect were found. 30192917 2019
CUI: C0871388
Disease: social stress
social stress
0.020 AlteredExpression disease BEFREE Stress was induced via the Trier Social Stress Test and salivary alpha-amylase and cortisol levels were measured throughout the experiment. 31280058 2019
CUI: C0871388
Disease: social stress
social stress
0.020 Biomarker disease BEFREE The current longitudinal study investigates associations between overweight/obesity, salivary alpha amylase and cortisol morning intercept, diurnal slope, and reactivity to social stress in a cohort of low-income children during preschool and middle childhood. 31477784 2020
CUI: C1279420
Disease: Anxiety neurosis (finding)
Anxiety neurosis (finding)
0.020 Biomarker disease BEFREE No mediating roles of salivary alpha-amylase and anxiety state in the cGxE effect were found. 30192917 2019
CUI: C1279420
Disease: Anxiety neurosis (finding)
Anxiety neurosis (finding)
0.020 Biomarker disease BEFREE Immediately before and after a mindfulness session, participants completed questionnaires to assess the short-term effects on mood and state anxiety and provided saliva samples to assess salivary alpha amylase (sAA) concentrations. 30395806 2019
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.010 Biomarker disease BEFREE This study investigated a possible correlation between opiorphin and stress/immune biomarkers, cortisol, salivary alpha-amylase (sAA) and secretory immunoglobulin A (sIgA), in saliva of patients with restrictive-type AN. 30880537 2019
CUI: C0004352
Disease: Autistic Disorder
Autistic Disorder
0.010 Biomarker disease BEFREE Salivary α-amylase as a marker of stress reduction in individuals with intellectual disability and autism in response to occupational and music therapy. 29159888 2018
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.010 AlteredExpression disease BEFREE Interestingly, we detected elevated basal (<i>p</i> = 0.015) and stimulated (<i>p</i> = 0.021) sAA levels in the UC populations compared to controls. 29977288 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE Several studies recently reported contradicting results regarding the link between amylase 1 (AMY1) copy numbers (CNs), obesity, and type 2 diabetes. 30982860 2019
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.010 Biomarker disease BEFREE Low AMY1 CNVs correlated with high insulin resistance in asymptomatic Korean men, and such a relationship presented differently according to the status of smoking and alcohol consumption. 25996848 2015
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.010 AlteredExpression disease BEFREE Our data suggest that amylase-producing myeloma reduced the sensitivity to bortezomib in vitro and in vivo, and the up-regulation of TCL1A may influence the drug susceptibility of 8226/AMY1 via the phosphorylation of Akt. 26341959 2015
CUI: C0038436
Disease: Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
0.010 AlteredExpression disease BEFREE These findings suggest that the relationship between fear extinction and PTSD symptoms does not change as a function of sAA levels; however previous research suggests other processes of fear learning may be associated with noradrenergic activity in PTSD. 29494868 2018
CUI: C0085159
Disease: Seasonal Affective Disorder
Seasonal Affective Disorder
0.010 Biomarker disease BEFREE After treatment, children with SAD in the waitlist group differed from children with SAD in the CBT group by showing stronger cortisol reactivity and a higher responder rate, indicative of a possible sensitization to stress.No difference was found for sAA. 31386987 2019
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.010 AlteredExpression disease BEFREE The AMY1 gene (salivary type) was exclusively and highly expressed in the salivary glands and the amylase-producing lung adenocarcinomas. 7507116 1994
CUI: C0221773
Disease: Hyperamylasemia
Hyperamylasemia
0.010 GeneticVariation disease BEFREE Coexpression of the AMY1 gene and AMY2 gene (pancreatic type) was observed in most of the lung cancers without hyperamylasemia, lung tissue, and cells scraped from the tracheal epithelium, thyroid, and female genital tract (ovary, fallopian tube, and uterus cervix), while minimal levels of mRNA transcripts of the AMY2 gene were detected in other malignant neoplasms, various normal tissues, and the cultured cell lines. 7507116 1994
CUI: C0235013
Disease: Hypervigilance
Hypervigilance
0.010 Biomarker disease BEFREE Resting amygdala connectivity and basal salivary alpha-amylase (sAA) and cortisol were tested as neural and neuroendocrine markers of hypervigilance, respectively. 30529716 2019
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.010 AlteredExpression disease BEFREE Concerning sAA, MDD patients had higher sAA levels upon awakening on two consecutive days (p = 0.04, p = 0.01 respectively), as well as a higher area under the curve with respect to the increase (AUCi; p = 0.04) in comparison to both controls and the other MAS-disorders group. 30005283 2018
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.010 GeneticVariation disease BEFREE Coexpression of the AMY1 gene and AMY2 gene (pancreatic type) was observed in most of the lung cancers without hyperamylasemia, lung tissue, and cells scraped from the tracheal epithelium, thyroid, and female genital tract (ovary, fallopian tube, and uterus cervix), while minimal levels of mRNA transcripts of the AMY2 gene were detected in other malignant neoplasms, various normal tissues, and the cultured cell lines. 7507116 1994
CUI: C0270327
Disease: Bedwetting
Bedwetting
0.010 Biomarker disease BEFREE T&A has a favorable therapeutic effect on NE and may decrease SNA in children with OSAS. sAA might be associated with instability of ANS by OSAS and have a consistent relationship with the apnea-hypopnea index.Our studying aims had been met. 27876406 2017
CUI: C0270549
Disease: Generalized Anxiety Disorder
Generalized Anxiety Disorder
0.010 Biomarker disease BEFREE The change of sAA after stroop test in GAD patients can predict the severity of anxiety, but subjective psychological perception can not. 31726179 2020
CUI: C1096155
Disease: Macrophage Activation Syndrome
Macrophage Activation Syndrome
0.010 AlteredExpression disease BEFREE Concerning sAA, MDD patients had higher sAA levels upon awakening on two consecutive days (p = 0.04, p = 0.01 respectively), as well as a higher area under the curve with respect to the increase (AUCi; p = 0.04) in comparison to both controls and the other MAS-disorders group. 30005283 2018